CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
CASI Pharmaceuticals's cash was $5.63M at Dec 31, 2025. For fiscal 2025 it was $5.63M, down 58.2% from the year before. The highest annual figure on record is $48.57M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.63M | -58.2% |
| FY2024 | Dec 31, 2024 | $13.47M | -53.7% |
| FY2023 | Dec 31, 2023 | $29.09M | -40.1% |
| FY2022 | Dec 31, 2022 | $48.57M | +0.0% |
| FY2021 | Dec 31, 2021 | $48.57M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $5.63M | -88.4% |
| Q4 FY2024 | Dec 31, 2024 | $13.47M | – |
| Q4 FY2023 | Dec 31, 2023 | $29.09M | – |
| Q4 FY2022 | Dec 31, 2022 | $48.57M | – |
| Q4 FY2021 | Dec 31, 2021 | $48.57M | – |
See a number that looks wrong?